Ligand Pharmaceuticals IncorporatedLGNDNASDAQ
Loading
Income Tax Expense Over TimeExpanding
Percentile Rank79
3Y CAGR-5.8%
Studio
Year-over-Year Change

Income taxes paid or accrued

3Y CAGR
-5.8%/yr
vs +8.3%/yr prior
Acceleration
-14.0pp
Decelerating
Percentile
P79
Within normal range
vs 3Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$34.51M+426.8%
2024$6.55M-33.4%
2023$9.84M-76.1%
2022$41.23M+1094.0%
2021$-4.15M+21.8%
2020$-5.31M-103.2%
2019$167.34M+457.6%
2018$30.01M-32.8%
2017$44.67M+332.6%
2016$10.33M-